CSAM Health Group AS carries a market capitalization of 98.80M, placing it among publicly traded companies globally. Its enterprise value stands at 1.52B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 98.80M |
| Enterprise Value | 1.52B |
CSAM Health Group AS currently has 20.51M shares outstanding.
| Shares Outstanding | 20.51M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
CSAM Health Group AS trades at a trailing price-to-earnings ratio of 11.09. The price-to-sales ratio is 2.48, and the price-to-book ratio stands at 513.15.
| PE Ratio | 11.09 |
| PS Ratio | 2.48 |
| PB Ratio | 513.15 |
| P/TBV Ratio | -2.04 |
| P/FCF Ratio | 13.13 |
| P/OCF Ratio | 13.13 |
On an enterprise value basis, CSAM Health Group AS trades at an EV/EBITDA multiple of 91.14 and an EV/FCF ratio of 10.76. The EV/Sales ratio of 3.44 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 91.14 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.44 |
| EV / EBITDA | 91.14 |
| EV / EBIT | 91.14 |
| EV / FCF | 10.76 |
CSAM Health Group AS maintains a current ratio of 0.73, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,484.68, indicating moderate leverage, while an interest coverage ratio of 0.28 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.73 |
| Quick Ratio | 0.27 |
| Debt / Equity | 1,484.68 |
| Debt / EBITDA | 29.08 |
| Interest Coverage | 0.28 |
| Return on Equity (ROE) | -1,806.95 |
| Return on Assets (ROA) | -4.95 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 122.18 |
| Income Tax | -1.38M |
| Effective Tax Rate | N/A |
CSAM Health Group AS's stock has declined approximately -0.04564315% over the past 52 weeks. The 50-day moving average sits at 4.82, while the 200-day moving average is 4.82.
| Beta (5Y) | N/A |
| 52-Week Price Change | -0.04564315% |
| 50-Day Moving Average | 4.82 |
| 200-Day Moving Average | 4.82 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CSAM Health Group AS generated 440.90M in revenue and converted that into -38.21M in net income, yielding earnings per share of -1.88. EBITDA reached 16.66M, while operating income came in at 16.66M.
| Revenue | 440.90M |
| Gross Profit | 409.74M |
| Operating Income | 16.66M |
| Pretax Income | -39.59M |
| Net Income | -38.21M |
| EBITDA | 16.66M |
| EBIT | 16.66M |
| Earnings Per Share (EPS) | -1.88 |
CSAM Health Group AS holds 59.99M in cash and equivalents against 484.60M in total debt, resulting in a net debt position of 424.61M. Total book value stands at 2.13M, with working capital of -58.55M providing operational flexibility.
| Cash & Cash Equivalents | 59.99M |
| Total Debt | 484.60M |
| Net Debt | 424.61M |
| Equity (Book Value) | 2.13M |
| Book Value Per Share | 0.10 |
| Working Capital | -58.55M |
CSAM Health Group AS produced 83.32M in operating cash flow over the past twelve months.
| Operating Cash Flow | 83.32M |
| Capital Expenditures | N/A |
| Free Cash Flow | 83.32M |
| FCF Per Share | 4.10 |
CSAM Health Group AS operates with a gross margin of 92.93, reflecting its pricing power and cost economics. The operating margin of 3.78 and net profit margin of -8.67 provide insight into operational efficiency.
| Gross Margin | 92.93 |
| Operating Margin | 3.78 |
| Pretax Margin | -8.98 |
| Profit Margin | -8.67 |
| EBITDA Margin | 3.78 |
The company's payout ratio of -25.50 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.48 |
| Dividend Yield | N/A |
| Payout Ratio | -25.50 |
| Shareholder Yield | 6.01 |
| FCF Yield | 7.62 |
CSAM Health Group AS posts an Altman Z-Score of 2.98, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.98 |